CYP24A1 loss-of-function mutation as a rare cause of parathyroid (PTH)-independent severe hypercalcaemia in pregnancy

Abstract

Get full access to this article

View all access options for this article.

References

Gilkinson

Beresford

Postlethwaite

, et al. A rare example of humoral-related hypercalcaemia in pregnancy secondary to a uterine fibroid: a case report. Obstet Med 2025: 1753495X251326130. DOI: https://doi.org/10.1177/1753495X251326130

Cappellani

Brancatella

Morganti

, et al. Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review. Eur J Endocrinol 2022; 186: 137–149.

Pilz

Theiler-Schwetz

Pludowski

, et al. Hypercalcemia in pregnancy due to CYP24A1 mutations: case report and review of the literature. Nutrients 2022; 14: 2518. DOI: https://doi.org/10.3390/nu14122518

Lemaitre

Lionet

Fages

, et al. Case report: non-PTH-dependent hypercalcemia in pregnancy: consider CYP24A1 mutations. Ann Endocrinol (Paris) 2023; 84: 758–760.

Brancatella

Cappellani

Kaufmann

, et al. Long-term efficacy and safety of rifampin in the treatment of a patient carrying a CYP24A1 loss-of-function variant. J Clin Endocrinol Metab 2022; 107: e3159–e3166.